Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection?

Archives of Surgery

Volumn 135, Issue 11, 2000, Pages 1329-1333

  Jeng, Kuo Shyang ^a   Sheen, I Shyan ^b   Chen, Be Fong ^a   Wu, Ju Yann ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; FORMALDEHYDE; MONOCLONAL ANTIBODY; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER GRADING; CANCER INHIBITION; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TISSUE SECTION; TUMOR SUPPRESSOR GENE;

EID: 0033755364     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.135.11.1329     Document Type: Article

References (8)

1. Bartek J, Bartkova J, Vojtesek B, et al. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene. 1991;6:1699-1703.
2. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 Mutations in human cancers. Science. 1991;253:49-53.
3. Collier JD, Carpenter M, Burt AD, Bassendine MF. Expression of mutant p53 protein in hepatocellular carcinoma. Gut 1994;35:98-100.
4. Livni N, Eid A, Ilan Y, et al. p53 Expression in patients with cirrhosis with and without hepatocellular carcinoma. Cancer. 1995;75:2420-2426.
5. Saegusa M, Takano Y, Kishimoto H, Wakabayashi G, Nohga K, Okudaira M. Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas: an enhanced immunohistochemical approach. J Cancer Res Clin Oncol. 1993;119:737-744.
6. Derrico A, Grigioni WF, Fiorentino M, Baccarini P, Grazi GL, Mancini AM. Overexpression of p53 protein and Ki 67 proliferative index in hepatocellular carcinoma: an immunohistochemical study on 109 Italian patients. Pathol Int. 1994;44:682-687.
7. Ng IO, Srivastava G, Chung LP, Tsang SW, Ng MM. Overexpression and point mutations of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people. Cancer. 1994;74:30-37.
8. Cohen C, DeRose PB. Immunohistochemical p53 in hepatocellular carcinoma and liver cell dysplasia. Mod Pathol. 1994;7:536-539.